| Records |
| Author |
Silins, Edmund; Bleeker, Anne M.; Copeland, Jan; Dillon, Paul; Devlin, Kristina; van Bakkum, Floor; Noijen, Judith |
| Title |
The importance of peer educator qualities : as perceived by ecstasy users |
Type |
Journal Article |
| Year |
2010 |
Publication |
SuchtMagazin |
Abbreviated Journal |
|
| Volume |
36 |
Issue |
5; 10/2010 |
Pages |
17-20 |
| Keywords |
nightlife; AOD use; psychoactive substances; conference proceedings; journal article |
Abstract  |
This study investigated the importance of peer educator qualities among ecstasy users in Australia (n=661) and the Netherlands (n=265). Experience with illicit drug use, an affinity with the ecstasy-using subculture and age emerged as important peer educator characteristics. In the Netherlands, more importance was placed on the peer educator having used illicit drugs and less importance was placed on age, subculture membership, being «cool» and gender than in Australia. The implications for peer-led ecstasy-related education practices are discussed. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
|
Place of Publication |
|
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
1422-2221 |
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Auch auf Deutsch vorhanden |
Approved |
no |
| Call Number |
60.01-001 |
Serial |
60484 |
| Permanent link to this record |
| |
|
| |
| Author |
Ogborne, Alan C.; Carver, Virginia; Wiebe, Jamie |
| Title |
Harm reduction and injection drug use : an international comparative study of contextual factors influencing the development and implementation of relevant policies and programs |
Type |
Report |
| Year |
2001 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
iv, 119 |
| Keywords |
harm reduction; harm reduction policy; intravenous injection; infection; HIV infection; Aids; hepatitis C; program planning; program implementation; Canada; Australia; Germany; Netherlands; Switzerland; United Kingdom |
| Abstract |
This study examined the socio-political context for harm reduction initiatives related to injection drug use and HIV/AIDS and HCV in Canada and five other countries: Australia, Germany, the Netherlands, Switzerland and the United Kingdom. The aim was to identify options that might be considered to further harm reduction policies and practices in Canada. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Canadian Centre for Substance Abuse (CCSA) |
Place of Publication |
Ottawa |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Aussi disponible en français: 50-13440 |
Approved |
no |
| Call Number |
50-00826 |
Serial |
56734 |
| Permanent link to this record |
| |
|
| |
| Author |
Carpentier, Chloé; Mulligan, Kobie; Laniel, Laurent; Potter, David; Hughes, Brendan; Vandam, Liesbeth; Olszewski, Deborah; Skarupova, Katerina |
| Title |
Cannabis production and markets in Europe |
Type |
Report |
| Year |
2012 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
268 |
| Keywords |
cannabis; marijuana in any form; prevalence; drug market; plant and crop husbandry; drug consumption; drug laws; AOD price; AOD use, abuse, and dependence; AOD demand; AOD supply; study; international area; Europe; report |
| Abstract |
This study brings together available evidence to provide a comprehensive analysis of cannabis production and markets across the EU. It combines information from EMCDDA routine reporting – data on patterns of prevalence and use, seizures, police reports, drug-law offences, cannabis potency and retail market prices – with literature on cannabis markets to create an in-depth analysis of the issue in a European context. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
Carpentier, Chloé; Laniel, Laurent; Griffiths, Paul |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
Insights |
Abbreviated Series Title |
|
| Series Volume |
122 |
Series Issue |
|
Edition |
|
| ISSN |
1606-1683 |
ISBN |
978-92-9168-495-3 |
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12605 |
Serial |
56556 |
| Permanent link to this record |
| |
|
| |
| Author |
Reuter, Peter; Schnoz, Domenic |
| Title |
Assessing drug problems and policies in Switzerland, 1998-2007 |
Type |
Report |
| Year |
2009 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
80 |
| Keywords |
addiction; AOD dependence; chemical addiction; government and politics; Switzerland |
| Abstract |
This study aims to describe how the drug problems of Switzerland have changed over the period 1998-2007, what policies were implemented during that period and to assess, to the extent possible, how well those policies have worked in reducing the nation’s drug problems. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
University of Maryland, School of Public Policy and Department of Criminology; Institut für Sucht- und Gesundheitsforschung (ISGF) |
Place of Publication |
College Park; Zurich |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Synthèse du rapport (en français) aussi disponible: 50-10923 |
Approved |
no |
| Call Number |
50-10922 |
Serial |
56342 |
| Permanent link to this record |
| |
|
| |
| Author |
European Monitoring Centre for Drugs and Drug Addiction |
| Title |
Prisons and drugs in Europe : the problem and responses |
Type |
Report |
| Year |
2012 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
31 |
| Keywords |
health and disease; health care administration; prison-based prevention; treatment and maintenance; counseling; intravenous drug user; infection; risk-taking behavior; AODR mortality; international area; Europe; European Union |
| Abstract |
This Selected issue starts off by reviewing the available data on drug use among prison populations in Europe, focusing on injecting drug use and other health risk behaviours. Major health risks for drug-using prisoners, including blood-borne infections and infections that can affect all prisoners equally, such as tuberculosis, are discussed. Also mentioned is the role of prison environments, where overcrowding and unsanitary conditions are not uncommon, and the higher-than-average occurrence of psychiatric problems among prisoners. The first section concludes by describing the increased risk of death among prisoners, both in custody and after release. The second part of the report focuses on responses to the health needs of drug-using prisoners in European countries. The study looks at how the internationally recognised rights of prisoners and the European and international rules that set standards for the care of prisoners apply to those with drug problems. The administration of prison healthcare in European countries is examined, and national policies are reviewed. This is followed by an overview of the available information on drug-related service provision in Europe, from prison entry to prison release, addressing counselling, treatment of drug dependence and the prevention of infectious diseases and drug overdose. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12855 |
Serial |
51036 |
| Permanent link to this record |
| |
|
| |
| Author |
European Monitoring Centre for Drugs and Drug Addiction |
| Title |
Annual report 2005 : selected issues |
Type |
Report |
| Year |
2005 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
45 |
| Keywords |
government and politics; international area; Europe |
| Abstract |
This Selected issue is not intended to present a systematic and exhaustive review either of all possible definitions of drug-related public nuisance or of all measures, provisions and policies aimed at reducing the problem in the European Union, nor does it aim to reflect precisely the situation regarding public nuisance in each of the countries concerned. Rather, it seeks to contribute to our understanding of the issues and problems related to a new – and somewhat still limited – area for intervention in Member States, candidate countries and Norway. This document aims to present the first EMCDDA qualitative insight into an emerging concern within drug policy debate, at both national and European levels. The alternatives to prison that may be offered to drug-using offenders cover a range of sanctions that may delay, avoid, replace or complement prison sentences for those drug users who have committed an offence normally sanctioned with imprisonment by national law. In this Selected issue, the focus is on those measures that have a drug-related treatment component. It will describe the political and legal background, the application and implementation, including common problems, and the effects of treatment as an alternative to imprisonment. Since the mid-1990s buprenorphine has increasingly become available in Europe as an alternative to methadone for the treatment of opiate dependence. In this Selected issue, the reasons why clinicians are attracted to this drug, as well as the costs and benefits of buprenorphine in comparison with other treatment options, are explored in detail, and, for the first time, the increasing popularity of buprenorphine for the treatment of opiate dependence in many European countries is documented. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
Selected issues |
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
1725-5295 |
ISBN |
92-9168-246-2 |
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
13.02-057 |
Serial |
51132 |
| Permanent link to this record |
| |
|
| |
| Author |
|
| Title |
Pregnancy, childcare and the family : key issues for Europe's response to drugs |
Type |
Report |
| Year |
2012 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
27 |
| Keywords |
AOD use, abuse, and dependence; AOD user; AOD associated consequences; risk; pregnancy; family; parent; child; public policy on health; international area; Europe; European Union |
| Abstract |
This Selected issue gives a broad overview on the extent of, and available responses to, the problems of pregnant drug users and families that are affected by drug use. In the first part of the report, a description of the available data on the extent of drug use during pregnancy and associated risks is followed by a review of responses to drug use among pregnant women across Europe. The second part of the publication focuses on children living in the care of drug users. Here, a review of the risks related to drug use in the family sets the scene for European overviews of responses targeting drug-using parents and responses aimed at the children of drug users. The policy and legal frameworks concerning the two situations are described, both for pregnant drug users and drug-using parents and their children. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12854 |
Serial |
51035 |
| Permanent link to this record |
| |
|
| |
| Author |
various |
| Title |
Risk assessment report of a new psychoactive substance : 4-methylmethcathinone (mephedrone) : in accordance with Article 6 of Council Decision 2005/387/JHA on information; exchange, risk assessment and control of new psychoactive substances |
Type |
Report |
| Year |
2010 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
16, annexes |
| Keywords |
addiction; AOD use, abuse, and dependence; chemical addiction; other AOD substances; mephedrone; designer drug; research chemical; risk assessment; law enforcement; search and seizure; organized crime; Europe |
| Abstract |
This Risk Assessment Report presents the summary findings and the conclusions of the risk assessment carried out by the EMCDDA’s extended Scientific Committee of the new psychoactive substance 4-methylmethcathinone (hereinafter ‘mephedrone’). |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) |
Place of Publication |
Lisbon |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Annex 1: Paul Dargan, David Wood: Technical report on mephedrone; Guy’s and St Thomas’ NHS Foundation Trust; London, July 2010; 67 pp. |
Approved |
no |
| Call Number |
50-11503 |
Serial |
56404 |
| Permanent link to this record |
| |
|
| |
| Author |
Dolan, Kate; Topp, Libby; MacDonald, Margaret |
| Title |
Needle and syringe programs : a review of the evidence |
Type |
Book Whole |
| Year |
2000 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
30 |
| Keywords |
harm reduction; needle distribution and exchange; program evaluation; international area; Australia |
| Abstract |
This Review summarises the literature on the provision of sterile injecting equipment to people who inject drugs and other related issues. The proportion of the Australian population thought to inject drugs is about one percent or approximately 275,000 people. The first case of HIV infection in a drug injector without other risk factors in Australia was detected in 1985. In the following year, a Needle and Syringe Program started in Australia. At that time, hepatitis C infection was already well established among drug injectors with more than half being infected2. Staff at Needle and Syringe Programs provide much more than injecting equipment. They are often the first point of contact with health services for people who inject drugs, facilitating the entry of many drug users into drug treatment. Some Programs also provide primary medical care to this disadvantaged section of Australians whose health is usually very poor. Needle and Syringe Programs have reduced the transmission of HIV, hepatitis B and hepatitis C. The size of the reduction of HIV transmission due to Needle and Syringe Programs has been calculated to be at least 30 percent. Australia’s Needle and Syringe Programs were estimated to have prevented almost 3,000 cases of HIV infection in 1991 alone, a saving of $266 million. HIV epidemics have occurred recently in some cities in North America where Needle and Syringe Programs existed. Arbitrary restrictions on the number of needles and syringes provided from the Programs are thought to have been a critical weakness in their effectiveness in preventing transmission of blood borne viral infections. Research has shown that Needle and Syringe Programs do not increase injecting drug use or the number of discarded needles and syringes. Even though Needle and Syringe Programs enjoy a high level of support from the public in Australia and abroad, they also attract some criticism. Objections to Needle and Syringe Programs include: concern about specific locations, the inconsistency in providing some free injecting equipment to drug injectors but not to people with diabetes, concern that the Programs are responsible for all discarded injecting equipment in a local area and that the Programs condone drug use. Some members of the public are concerned that they may receive a needlestick injury from a discarded needle and syringe and then become infected with HIV or hepatitis. No cases of HIV, hepatitis B or hepatitis C infection resulting from a needlestick injury due to discarded injection equipment have been identified although researchers have investigated the outcomes of such injuries. There is abundant evidence from Australia and other countries of the public health benefits of Needle and Syringe Programs. The US Secretary for Health and Human Services, Donna Shalala, has announced that: “This nation is fighting two deadly epidemics – AIDS and drug abuse. They are robbing us of far too many of our citizens and weakening our future. A meticulous scientific review has now proven that needle exchange programs can reduce the transmission of HIV and save lives without losing ground in the battle against illegal drugs. It offers communities that decide to pursue needle exchange programs yet another weapon in the fight against AIDS (20 April 1998)” Countries that have implemented these Programs have averted HIV epidemics among injecting drug users, while countries that have not implemented these measures have often experienced uncontrolled epidemics. There is strong evidence that if HIV becomes endemic among injecting drug users, HIV can then spread to their sexual partners and children resulting in high mortality rates and large social and economic costs to the entire population. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Australian National Council on AIDS, Hepatitis C and Related Diseases (ANCAHRD) |
Place of Publication |
Sydney |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-13377 |
Serial |
54510 |
| Permanent link to this record |
| |
|
| |
| Author |
Burkhart, Gregor; Fegert, Jörg M.; Schepker, Renate; Keller, Ferdinand; Ludolph, Andrea G.; Plener, Paul L.; Williamson, Anette E.; Volmer-Berthele, Nora; Weninger, Laura E.; Kapusta, Nestor D.; 't Hart-Kerkhoffs, Lisette |
| Title |
Preventing later substance use disorders in at-risk children and adolescents : a review of the theory and evidence base of indicated prevention |
Type |
Report |
| Year |
2009 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
84 |
| Keywords |
indicated prevention; AODD and AODR disorder; child; adolescent; childhood; risk factors; AOD use, abuse, and dependence |
| Abstract |
This review on indicated prevention adds to the current knowledge and understanding of risk factors in the development of later drug problems and dependence, focusing on the mental health and behavioural problems that develop during childhood. Indicated prevention is a relatively new branch of drug prevention and can be seen as the third part of the ’prevention chain’, after universal and selective prevention. Its aim is not necessarily to prevent drug use or initiation to it, but rather to prevent the development of dependence, diminish frequency of use and avert ’dangerous’ patterns of substance use (e.g. moderate instead of binge-drinking). |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Lisbon; Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
1725-5767 |
ISBN |
987-92-9168-349-9 |
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-10121 |
Serial |
50662 |
| Permanent link to this record |
